Pier 70 Ventures

Pier 70 Ventures is a venture capital investment firm based in Seattle, Washington, founded in 2021. The firm focuses on funding disruptive technologies within the healthcare sector that have the potential to transform existing practices and improve outcomes. Pier 70 Ventures targets companies at various stages of development, including seed-stage, early-stage, and later-stage businesses, emphasizing innovation and significant impact within the healthcare industry.

Miller Adams

Co-Founder and Managing Partner

Robert Balk

Co-Founder and Venture Partner

Shaun Hawkins

Managing Partner

Preetha Ram

Managing Partner

6 past transactions

Flyte

Seed Round in 2024
Pelvital USA, Inc. is a privately held company based in Minneapolis, Minnesota, focused on restoring pelvic health and enhancing the quality of life for individuals suffering from pelvic floor disorders. Founded in 2016, the company is currently evaluating the Flyte system, an investigational medical device designed to strengthen and potentially heal the pelvic floor muscle system. This device employs a unique mechanotherapy technology, which has been shown to effectively heal and strengthen muscle systems. Through its innovative approach, Pelvital aims to provide significant improvements for patients dealing with pelvic floor issues.

PrīmSphera

Seed Round in 2023
PrīmSphera (fka Vital View Technologies) is a revolutionary sensor technology company pioneering break-through solutions to solve real-world challenges. Our vision is to create a contactless sensor platform to improve effective decision making by unlocking insights that are otherwise unavailable. With applications in defense, and food processing, PrīmSphera has selected Healthcare as a primary industry for the beachhead market. Founded as a catalyst to commercialize the research of Dr. Thomas Pratt at The University of Notre Dame, who is a pioneer in leveraging radio frequency polarization mode dispersion (RF-PMD) for a range of sensing applications. The name ‘PrīmSphera’ (Pryme-SFair-uh) embodies our mission to deliver pioneering solutions (‘Prīm’—meaning first) and highlights the unique spherical output of Dr. Thomas Pratt’s groundbreaking work. Today, PrīmSphera are actively developing its flagship product, a state-of-the-art connected solution for the hospital-at-home. This monitoring platform features a proprietary non-contact, at-home medical monitor that tracks fluid change over time. This provides early, actionable data to patients and clinicians to inform care plans.

KayoThera

Series A in 2023
KayoThera is a biotechnology company focused on developing innovative therapeutics aimed at treating late-stage and metastatic cancers. Founded in 2019 and based in Princeton, New Jersey, the company specializes in creating first-in-class immuno- and targeted therapies. Its primary approach involves inhibiting a key enzyme that protects cancer cells and depleting regulatory T-cells, which enhances the effectiveness of existing chemotherapy and immunotherapy treatments. KayoThera's mission is to provide new hope for patients facing previously incurable cancers by advancing its therapeutic programs.

Community

Venture Round in 2023
Community is a social engagement platform that enables seamless two-way communication between influencers and their audiences. By providing a unique 10-digit phone number, it connects businesses, brands, public figures, and creators directly with their consumers. The platform is designed to facilitate interaction without the negative aspects often associated with social media, such as conflicting commercial interests and data privacy concerns. Community’s approach allows influencers from various sectors, including global brands, sports teams, and artists, to engage with their audiences on a personal level, fostering genuine connections and enhancing overall engagement.

ZeroCarb LYFE

Venture Round in 2023
ZeroCarbLYFE is a food tech company with the mission to bring joy into healthy food. We invented multiple high proteins, and low/no carb foods that taste as good as or better than carb-loaded alternatives.

DocSpera

Series B in 2022
DocSpera is an integrated surgical coordination platform that enhances synchronization across multiple sites and teams, ultimately improving workflow efficiencies and patient care. The company's proprietary platform automates pre-surgical coordination and facilitates real-time, secure synchronization of cases and images among key stakeholders, including surgeons, care teams, and device suppliers, utilizing electronic health record data. Additionally, DocSpera's intelligent surgical planning capabilities allow for continuous patient monitoring from the surgical decision phase through recovery, providing real-time insights and operating room dashboards to support physicians in their decision-making processes. Headquartered in Sunnyvale, California, DocSpera operates under Compliant Innovations Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.